You are here

Prices & Quotes - UK Markets - Dechra Pharmaceuticals (DPH)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 3,920.00p
Change Today:
-10.00p
Market Cap:
4,241.55m
Sector:
Pharmaceuticals & Biotechnology
Select: Overview | Profit And Loss | Balance Sheet | Cash Flow | Key Financials

Geographical - by origin

  30-Jun-2030-Jun-1930-Jun-1830-Jun-1730-Jun-16
Revenue
Germany53.9010%48.2010%40.4010%37.4110%34.1014%
Rest of Europe173.8034%163.5034%138.3034%113.1231%91.7937%
Rest of World60.5012%44.609%32.508%n/an/an/an/a
UK45.009%56.4012%56.1014%56.3216%54.4222%
USA181.9035%169.1035%139.8034%n/an/a53.9122%
Unanalysedn/an/an/an/an/an/a152.4542%13.335%
Total 515.10100% 481.80100% 407.10100% 359.30100% 247.56100% 
 
Profit Before Tax
Unanalysed40.90100%27.80100%28.90100%28.60100%14.55100%
Total 40.90100% 27.80100% 28.90100% 28.60100% 14.55100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  30-Jun-2030-Jun-1930-Jun-1830-Jun-1730-Jun-16
Revenue
CAPn/an/an/an/an/an/a223.8362%137.6956%
Dietsn/an/an/an/an/an/a27.468%24.3811%
Equinen/an/an/an/an/an/a27.258%20.529%
European Pharmaceuticals323.5063%304.0063%258.7064%n/an/an/an/a
FAPn/an/an/an/an/an/a47.3115%38.1017%
North American Pharmaceuticals191.6037%177.8037%148.4036%n/an/an/an/a
Unanalysedn/an/an/an/an/an/a33.46n/a26.87n/a
Total 515.10100% 481.80100% 407.10100% 359.30100% 247.56100% 
 
Profit Before Tax
European Pharmaceuticals100.00n/a100.30n/an/an/an/an/an/an/a
North American Pharmaceuticals63.70n/a59.20n/an/an/an/an/an/an/a
Pharmaceuticals Research and Development(28.40)n/a(25.10)n/an/an/an/an/an/an/a
Unanalysed(94.40)n/a(106.60)n/a28.90n/a28.60n/a14.55n/a
Total 40.90n/a 27.80n/a 28.90n/a 28.60n/a 14.55n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.